A total of 4,677 Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP) Kendras were functional across the country by the end of 2018, providing quality generic medicines at affordable prices to the patients, Parliament was informed Friday.
Unbranded generic medicines worth Rs 417 crore have been sold through PMBJP Kendras from inception of the scheme till the end of December 2018, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said in reply to a question in the Rajya Sabha.
"As on 31.12.2018, 4,677 'Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana' (PMBJP) Kendras are functional in 35 States/UTs of the country," he said.
Under the scheme, unbranded generic medicines of good quality are made available through PMBJP Kendras. In order to ensure quality of medicines sold through the Kendras, the medicines are procured only from WHO-GMP certified manufacturers, Mandaviya said.
The product basket of the scheme covers more than 800 medicines and 154 surgicals and consumables covering 23 major therapeutic groups such as anti-infectives, anti-diabetics, cardiovasculars, anti-cancers, gastro-intestinal medicines among others, he added.
"The maximum retail price (MRP) of a medicine sold through PMBJP outlets is fixed in such a way that it is at least 50 per cent below the average MRP of corresponding top three brands of that medicine," Mandaviya said.
In some cases, the price is fixed at 90 per cent below the MRP of corresponding branded medicines, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
